CORRADO ADVISORS, LLC - ANTARES PHARMA INC ownership

ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 135 filers reported holding ANTARES PHARMA INC in Q3 2019. The put-call ratio across all filers is 2.05 and the average weighting 0.1%.

Quarter-by-quarter ownership
CORRADO ADVISORS, LLC ownership history of ANTARES PHARMA INC
ValueSharesWeighting
Q2 2019$26,000
+13.0%
7,850
-30.2%
0.02%
+130.0%
Q2 2015$23,000
-34.3%
11,250
-18.2%
0.01%
-41.2%
Q4 2014$35,000
+40.0%
13,7500.0%0.02%
+54.5%
Q3 2014$25,000
-32.4%
13,7500.0%0.01%
-31.2%
Q2 2014$37,000
-33.9%
13,7500.0%0.02%
-44.8%
Q3 2013$56,000
+14.3%
13,7500.0%0.03%
-12.1%
Q1 2013$49,000
-14.0%
13,750
-8.3%
0.03%
-15.4%
Q4 2012$57,000
-16.2%
15,000
-3.2%
0.04%
-11.4%
Q3 2012$68,00015,5000.04%
Other shareholders
ANTARES PHARMA INC shareholders Q3 2019
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 3,130,192$12,834,0005.32%
Velan Capital Investment Management LP 1,346,971$5,523,0005.12%
FIRST WILSHIRE SECURITIES MANAGEMENT INC 2,799,953$11,480,0004.03%
Sargent Investment Group, LLC 3,663,275$15,019,0003.78%
PERKINS CAPITAL MANAGEMENT INC 481,483$1,974,0001.62%
Rubric Capital Management LP 10,900,000$44,690,0001.62%
ORACLE INVESTMENT MANAGEMENT INC 1,720,000$7,052,0001.39%
Long Focus Capital Management, LLC 540,000$2,214,0000.28%
OBERWEIS ASSET MANAGEMENT INC/ 344,200$1,411,0000.28%
FIRETHORN WEALTH PARTNERS, LLC 84,069$345,0000.26%
View complete list of ANTARES PHARMA INC shareholders